Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Immunosuppressants 1.4.3 Anti-Inflammatory Drugs 1.4.4 Anti-Fibrotic Agents 1.4.5 Vasodilators 1.4.6 Corticosteroids 1.4.7 CFTR Modulators 1.4.8 Others 1.5 Market by Application 1.5.1 Global Orphan Lung Diseases Treatment Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Orphan Lung Diseases Treatment Market Size 2.2 Orphan Lung Diseases Treatment Growth Trends by Regions 2.2.1 Orphan Lung Diseases Treatment Market Size by Regions (2014-2025) 2.2.2 Orphan Lung Diseases Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Orphan Lung Diseases Treatment Market Size by Manufacturers 3.1.1 Global Orphan Lung Diseases Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Orphan Lung Diseases Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Orphan Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Orphan Lung Diseases Treatment Key Players Head office and Area Served 3.3 Key Players Orphan Lung Diseases Treatment Product/Solution/Service 3.4 Date of Enter into Orphan Lung Diseases Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Orphan Lung Diseases Treatment Market Size by Type (2014-2019) 4.2 Global Orphan Lung Diseases Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Orphan Lung Diseases Treatment Market Size (2014-2019) 5.2 Orphan Lung Diseases Treatment Key Players in United States 5.3 United States Orphan Lung Diseases Treatment Market Size by Type 5.4 United States Orphan Lung Diseases Treatment Market Size by Application 6 Europe 6.1 Europe Orphan Lung Diseases Treatment Market Size (2014-2019) 6.2 Orphan Lung Diseases Treatment Key Players in Europe 6.3 Europe Orphan Lung Diseases Treatment Market Size by Type 6.4 Europe Orphan Lung Diseases Treatment Market Size by Application 7 China 7.1 China Orphan Lung Diseases Treatment Market Size (2014-2019) 7.2 Orphan Lung Diseases Treatment Key Players in China 7.3 China Orphan Lung Diseases Treatment Market Size by Type 7.4 China Orphan Lung Diseases Treatment Market Size by Application 8 Japan 8.1 Japan Orphan Lung Diseases Treatment Market Size (2014-2019) 8.2 Orphan Lung Diseases Treatment Key Players in Japan 8.3 Japan Orphan Lung Diseases Treatment Market Size by Type 8.4 Japan Orphan Lung Diseases Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Orphan Lung Diseases Treatment Market Size (2014-2019) 9.2 Orphan Lung Diseases Treatment Key Players in Southeast Asia 9.3 Southeast Asia Orphan Lung Diseases Treatment Market Size by Type 9.4 Southeast Asia Orphan Lung Diseases Treatment Market Size by Application 10 India 10.1 India Orphan Lung Diseases Treatment Market Size (2014-2019) 10.2 Orphan Lung Diseases Treatment Key Players in India 10.3 India Orphan Lung Diseases Treatment Market Size by Type 10.4 India Orphan Lung Diseases Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Orphan Lung Diseases Treatment Market Size (2014-2019) 11.2 Orphan Lung Diseases Treatment Key Players in Central & South America 11.3 Central & South America Orphan Lung Diseases Treatment Market Size by Type 11.4 Central & South America Orphan Lung Diseases Treatment Market Size by Application 12 International Players Profiles 12.1 GSK 12.1.1 GSK Company Details 12.1.2 Company Description and Business Overview 12.1.3 Orphan Lung Diseases Treatment Introduction 12.1.4 GSK Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.1.5 GSK Recent Development 12.2 Pfizer 12.2.1 Pfizer Company Details 12.2.2 Company Description and Business Overview 12.2.3 Orphan Lung Diseases Treatment Introduction 12.2.4 Pfizer Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.2.5 Pfizer Recent Development 12.3 Celgene 12.3.1 Celgene Company Details 12.3.2 Company Description and Business Overview 12.3.3 Orphan Lung Diseases Treatment Introduction 12.3.4 Celgene Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.3.5 Celgene Recent Development 12.4 Novartis 12.4.1 Novartis Company Details 12.4.2 Company Description and Business Overview 12.4.3 Orphan Lung Diseases Treatment Introduction 12.4.4 Novartis Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.4.5 Novartis Recent Development 12.5 NPS Pharmaceuticals 12.5.1 NPS Pharmaceuticals Company Details 12.5.2 Company Description and Business Overview 12.5.3 Orphan Lung Diseases Treatment Introduction 12.5.4 NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.5.5 NPS Pharmaceuticals Recent Development 12.6 Auspex Pharmaceuticals 12.6.1 Auspex Pharmaceuticals Company Details 12.6.2 Company Description and Business Overview 12.6.3 Orphan Lung Diseases Treatment Introduction 12.6.4 Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.6.5 Auspex Pharmaceuticals Recent Development 12.7 Synageva BioPharma 12.7.1 Synageva BioPharma Company Details 12.7.2 Company Description and Business Overview 12.7.3 Orphan Lung Diseases Treatment Introduction 12.7.4 Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.7.5 Synageva BioPharma Recent Development 12.8 Roche 12.8.1 Roche Company Details 12.8.2 Company Description and Business Overview 12.8.3 Orphan Lung Diseases Treatment Introduction 12.8.4 Roche Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.8.5 Roche Recent Development 12.9 Sanofi 12.9.1 Sanofi Company Details 12.9.2 Company Description and Business Overview 12.9.3 Orphan Lung Diseases Treatment Introduction 12.9.4 Sanofi Revenue in Orphan Lung Diseases Treatment Business (2014-2019) 12.9.5 Sanofi Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Orphan Lung Diseases Treatment Key Market Segments Table Key Players Orphan Lung Diseases Treatment Covered Table Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Orphan Lung Diseases Treatment Market Size Market Share by Type 2014-2025 Figure Immunosuppressants Figures Table Key Players of Immunosuppressants Figure Anti-Inflammatory Drugs Figures Table Key Players of Anti-Inflammatory Drugs Figure Anti-Fibrotic Agents Figures Table Key Players of Anti-Fibrotic Agents Figure Vasodilators Figures Table Key Players of Vasodilators Figure Corticosteroids Figures Table Key Players of Corticosteroids Figure CFTR Modulators Figures Table Key Players of CFTR Modulators Figure Others Figures Table Key Players of Others Table Global Orphan Lung Diseases Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacies Case Studies Figure Retail Pharmacies Case Studies Figure Online Pharmacies Case Studies Figure Orphan Lung Diseases Treatment Report Years Considered Table Global Orphan Lung Diseases Treatment Market Size 2014-2025 (Million US$) Figure Global Orphan Lung Diseases Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Orphan Lung Diseases Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Orphan Lung Diseases Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Orphan Lung Diseases Treatment Market Share by Regions 2014-2019 Figure Global Orphan Lung Diseases Treatment Market Share by Regions 2014-2019 Figure Global Orphan Lung Diseases Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Orphan Lung Diseases Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Orphan Lung Diseases Treatment Market Share by Manufacturers (2014-2019) Figure Global Orphan Lung Diseases Treatment Market Share by Manufacturers in 2018 Table Global Orphan Lung Diseases Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Orphan Lung Diseases Treatment Product/Solution/Service Table Date of Enter into Orphan Lung Diseases Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Global Orphan Lung Diseases Treatment Market Size Share by Type (2014-2019) Figure Global Orphan Lung Diseases Treatment Market Size Market Share by Type (2014-2019) Table Global Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Global Orphan Lung Diseases Treatment Market Size Share by Application (2014-2019) Figure Global Orphan Lung Diseases Treatment Market Size Market Share by Application (2014-2019) Figure Global Orphan Lung Diseases Treatment Revenue Market Share by Application in 2018 Figure United States Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Orphan Lung Diseases Treatment Market Share (2018-2019) Table United States Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table United States Orphan Lung Diseases Treatment Market Share by Type (2014-2019) Table United States Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table United States Orphan Lung Diseases Treatment Market Share by Application (2014-2019) Figure Europe Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Orphan Lung Diseases Treatment Market Share (2018-2019) Table Europe Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Orphan Lung Diseases Treatment Market Share by Type (2014-2019) Table Europe Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Orphan Lung Diseases Treatment Market Share by Application (2014-2019) Figure China Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$) Table China Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$) Table China Key Players Orphan Lung Diseases Treatment Market Share (2018-2019) Table China Orphan Lung Diseases Treatment Market Size by Type (2014-20189) (Million US$) Table China Orphan Lung Diseases Treatment Market Share by Type (2014-2019) Table China Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table China Orphan Lung Diseases Treatment Market Share by Application (2014-2019) Figure Japan Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Orphan Lung Diseases Treatment Market Share (2018-2019) Table Japan Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Orphan Lung Diseases Treatment Market Share by Type (2014-2019) Table Japan Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Orphan Lung Diseases Treatment Market Share by Application (2014-2019) Figure Southeast Asia Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Orphan Lung Diseases Treatment Market Share (2018-2019) Table Southeast Asia Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Orphan Lung Diseases Treatment Market Share by Type (2014-2019) Table Southeast Asia Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Orphan Lung Diseases Treatment Market Share by Application (2014-2019) Figure India Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$) Table India Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$) Table India Key Players Orphan Lung Diseases Treatment Market Share (2018-2019) Table India Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table India Orphan Lung Diseases Treatment Market Share by Type (2014-2019) Table India Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table India Orphan Lung Diseases Treatment Market Share by Application (2014-2019) Figure Central & South America Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Orphan Lung Diseases Treatment Market Share (2018-2019) Table Central & South America Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Orphan Lung Diseases Treatment Market Share by Type (2014-2019) Table Central & South America Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Orphan Lung Diseases Treatment Market Share by Application (2014-2019) Table GSK Company Details Table GSK Revenue in Orphan Lung Diseases Treatment Business (2014-2019) (Million US$) Figure GSK Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table GSK Recent Development Table Pfizer Company Details Table Pfizer Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table Pfizer Recent Development Table Celgene Company Details Table Celgene Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure Celgene Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table Celgene Recent Development Table Novartis Company Details Table Novartis Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table Novartis Recent Development Table NPS Pharmaceuticals Company Details Table NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure NPS Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table NPS Pharmaceuticals Recent Development Table Auspex Pharmaceuticals Company Details Table Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure Auspex Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table Auspex Pharmaceuticals Recent Development Table Synageva BioPharma Company Details Table Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure Synageva BioPharma Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table Synageva BioPharma Recent Development Table Roche Company Details Table Roche Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table Roche Recent Development Table Sanofi Company Details Table Sanofi Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019) Table Sanofi Recent Development Table Global Orphan Lung Diseases Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Orphan Lung Diseases Treatment Market Size Share by Regions (2019-2025) Figure Global Orphan Lung Diseases Treatment Market Size Share by Regions in 2025 Figure United States Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Orphan Lung Diseases Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Orphan Lung Diseases Treatment Market Size by Product (2019-2025) Figure Global Orphan Lung Diseases Treatment Market Size by Product in 2025 Table Global Orphan Lung Diseases Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Orphan Lung Diseases Treatment Market Size by Application (2019-2025) Figure Global Orphan Lung Diseases Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GSK Pfizer Celgene Novartis NPS Pharmaceuticals Auspex Pharmaceuticals Synageva BioPharma Roche Sanofi